LAZZARATO, Loretta

LAZZARATO, Loretta  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.023 secondi).
Titolo Data di pubblicazione Autore(i) File
A NEW CLASS OF BISPHOSPHONATES WITH NO-DONOR PROPERTIES 2001 L. LAZZARATO
Amphiphile NO-donor antioxidants as polivalent drugs 2006 MARINI E; LAZZARATO L; CHEGAEV K; FRUTTERO R; GASCO A
BROAD SPECTRUM METALLO beta-LACTAMASES INHIBITORS: NEW TOOLS AGAINST CLINICALLY-RELEVANT CARBAPENEMASES 2022 Lazzarato, L.; Failla, M.; Gianquinto, E.; Bersani, M.; Bertarini, L.; Verri, A.; Vascon, F.; Sannio, F.; Verdirosa, F.; Beatrice, N.; De Luca, F.; Costi, M.P.; Cruciani, G.; Docquier, J.D.; Cendron, L.; Spyrakis, F.; Tondi, D.
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives 2012 M. Bertinaria; M. A. A. G. Shaikh; C. Cena; B. Rolando; L. Lazzarato; R. Fruttero; A. Gasco; G. E. Rovati; C. Buccellati; V. Capra; A. Sala
EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY. 2019 Stefano Guglielmo, Marialessandra Contino, Chiara Riganti, Barbara Rolando, Loretta Lazzarato
GIFC-2018 - BOOK OF ABSTRACTS 2018 muntoni e, battaglia l, marini e, giorgis m, lazzarato l, salaroglio ic, riganti c, martina k
New class of NO-donor soluble aspirins 2012 Marini E.; Rolando B.; Lazzarato L.; Joseph S.; Fruttero R.
NEW CLASS OF NO-DONORS WITH BONE SELECTIVITY 2003 L. LAZZARATO; LOLLI M.L; BALBO S; DELEIDE G; FRUTTERO R
New NO-donor Bisphosphonates 2001 L. LAZZARATO; LOLLI M.L; DI STILO A; FRUTTERO R; GASCO A
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. 2013 Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo
Nitrooxymethyl substituted analogues of Celecoxib and Rofecoxib 2007 BOSCHI D; CENA C; LAZZARATO L; MARINI E; FRUTTERO R.; GASCO A.
Nitrooxymethyl substituted analogues of celecoxib as potential antitumoral drugs with reduced cardiotoxicity 2008 Boschi D; Lazzarato L; Filieri A; Miglietta A; Bocca C; Fruttero R; Gasco A.
NO donor - melatonins: a new class of potential antiatherosclerosis agents 2005 CHEGAEV K; LAZZARATO L; GIORGIS M; CENA C; DI STILO A; FRUTTERO R; GASCO A; LUCINI V; PANNACI M
NO-Donor Cyanines As Potential Anti-Alzheimer Drugs 2011 Federico A.; Chegaev K.; Lazzarato L.; Marini E.; Fruttero R.; Gasco A.
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors 2010 Roberta Fruttero; Loretta Lazzarato; Konstantin Chegaev; Barbara Rolando; Donatella Boschi; Claudiu T. Supuran; Alessio Innocenti; Alberto Gasco
Novel amphiphilic nitric oxide releasing antioxidants: NMR spectroscopic study of their interaction with biomembrane models 2005 LOPEZ V; LAZZARATO L; CHEGAEV K; ROLANDO B; FRUTTERO R; GASCO A
NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY 2013 Konstantin Chegaev; Loretta Lazzarato; Barbara Rolando; Chiara Riganti; Roberta Fruttero; Alberto Gasco